Innovation Backed by Experience and Vision

St Andrews Pharmaceutical Technology was set up in 2020 ​to deliver innovation where it has the greatest impact on life sciences, unlocking high‑performance cell cultures in a broad range of laboratory applications. The focus lies in translating scientific advances into practical solutions that drive measurable improvements in cell biology workflows

By enhancing cell growth profiles Pulzar promotes a stronger and more reliable performance in laboratory operation. Pulzar further extends this capability by transforming transfection workflows, improving efficiency and consistency at a critical stage of cell line and process development 

The result is a step change in cell culture capability, enabling greater output, consistency, and value across life sciences processes

The company has benefitted from both the expertise of its highly qualified scientists and advisors and the significant biomanufacturing and industrial experience of its team

The applications of Pulzar Technology are protected by multiple international patent applications and extensive company know-how

St Andrews Pharmaceutical Technology is a private limited company registered in the UK and based in St Andrews, Fife, Scotland

The company is funded by a European private family investment house and highly experienced American biotech entrepreneurs